19750 Federal Register / Vol. 60, No. 76 / Thursday, April 20, 1995 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made final findings of scientific

misconduct in the following case:

James T. Kurtzman, M.D., University

of California at San Francisco. An

investigation conducted by the

University found that Dr. Kurtzman, a

former Resident/Fellow in the

Department of Obstetrics, Gynecology,

and Reproductive Sciences, falsified

results of research on the kinetics of

nitric oxide synthase in cells and

homogenates of human myometrial

tissue in pregnant women. Dr. Kurtzman

admitted that he had altered data in

eight experiments that he performed

during December 1993 and January

1994. Dr. Kurtzman reported that he had

conducted the enzyme assays and

entered the data into a computer-based

spreadsheet, but then changed the data

to generate graphs that would reproduce

the type of results that he had submitted

earlier to the Journal of Clinical

Investigation. The paper was not

published. Dr. Kurtzman executed a

Voluntary Exclusion and Settlement

Agreement in which he has agreed not

to apply for Federal grant or contract

funds and will not serve on PHS

advisory committees, boards or peer

review groups for a three-year period

beginning March 18, 1995. The

voluntary exclusion, however, shall not

apply to Dr. Kurtzman’s future training

or practice of clinical medicine whether

as a resident, fellow, or licensed

practitioner, as the case may be, unless

that practice involves federally funded

research or the direct receipt of an

award for federally funded research

training.

FOR FURTHER INFORMATION, CONTACT:

Director, Division of Research

Investigations, Office of Research

Integrity, 301–443–5330.

Lyle W. Bivens,

Director, Office of Research Integrity.

[FR Doc. 95–9754 Filed 4–19–95; 8:45 am]

BILLING CODE 4160–17–P

Agency for Health Care Policy and

Research

Notice of Health Care Policy and

Research Special Emphasis Panel

Meeting

In accordance with section 10(a) of

the Federal Advisory Committee Act (5

U.S.C., Appendix 2) announcement is

made of the following special emphasis

panel scheduled to meet during the

month of May 1995:

Name: Health Care Policy and Research

Special Emphasis Panel.

Date and Time: May 8–9, 1995, 8:00 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Palladian East Room,

Chevy Chase, MD 20815.

Open May 8, 8:00 a.m. to 9:00 a.m. Closed

for remainder of meeting.

Purpose: This Panel is charged with

conducting review of Health Services

Research grant applications requesting

dissertation support.

Agenda: The open session of the meeting

on May 8, from 8:00 a.m. to 9:00 a.m. will

be devoted to a business meeting covering

administrative matters. During the closed

session, the committee will be reviewing

Health Services Research grant applications

requesting dissertation support. In

accordance with the Federal Advisory

Committee Act, section 10(d) of 5 U.S.C.,

Appendix 2 and 5 U.S.C., 552b(c)(6), the

Administrator, AHCPR, has made a formal

determination that this latter session will be

closed because the discussions are likely to

reveal personal information concerning

individuals associated with the grant

applications. This information is exempt

from mandatory disclosure.

Anyone wishing to obtain a roster of

members or other relevant information

should contact J. Terrell Hoffeld, D.D.S.,

Ph.D., Agency for Health Care Policy and

Research, Suite 602, 2101 East Jefferson

Street, Rockville, Maryland 20852,

Telephone (301) 594–1449.

Agenda items for this meeting are subject

to change as priorities dictate.

Dated: April 13, 1995.

Clifton R. Gaus,

Administrator.

[FR Doc. 95–9757 Filed 4–19–95; 8:45 am]

BILLING CODE 4160–90–M

Agency for Health Care Policy and

Research

Notice of Health Care Policy and

Research Special Emphasis Panel

Meeting

In accordance with section 10(a) of

the Federal Advisory Committee Act (5

U.S.C., Appendix 2) announcement is

made of the following special emphasis

panel scheduled to meet during the

month of June 1995:

Name: Health Care Policy and Research

Special Emphasis Panel

Date and Time: June 15–16, 1995, 8:30 a.m.

Place: Ramada Inn, 1775 Rockville Pike,

Montrose Room, Rockville, MD 20852.

Open June 15, 8:30 a.m. to 9:30 a.m. Closed

for remainder of meeting.

Purpose: This Panel is charged with

conducting the initial review of grant

applications on research that will provide

convincing evidence for or against the

effectiveness and cost effectiveness of

alternative clinical interventions used to

prevent, diagnose, treat, and manage

common clinical conditions.

Agenda: The open session for the meeting

on June 15, from 8:30 a.m. to 9:30 a.m. will

be devoted to a business meeting covering

administrative matters. During the closed

session, the committee will be reviewing

grant applications dealing with complex,

clinical medical effectiveness issues in

response to the medical treatment

effectiveness PORT II initiative. In

accordance with the Federal Advisory

Committee Act, section 10(d) of 5 U.S.C.,

Appendix 2 and 5 U.S.C., 552b(c)(6), the

Administrator, AHCPR, has made a formal

determination that this latter session will be

closed because the discussions are likely to

reveal personal information concerning

individuals associated with the grant

applications. This information is exempt

from mandatory disclosure.

Anyone wishing to obtain a roster of

members or other relevant information

should contract Gerald E. Calderone, Ph.D.,

Agency for Health Care Policy and Research,

Suite 602, 2101 East Jefferson Street,

Rockville, Maryland 20852, Telephone (301)

594–2462.

Agenda items for this meeting are subject

to change as priorities dictate.

Dated: April 13, 1995.

Clifton R. Gaus,

Administrator.

[FR Doc. 95–9758 Filed 4–19–95; 8:45 am]

BILLING CODE 4160–90–M

Centers for Disease Control and

Prevention

[Announcement 600]

Public Health Conference Support

Grant Program

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of funds in fiscal year (FY)

1996 for the Public Health Conference

Support Grant Program. The Public

Health Service (PHS) is committed to

achieving the health promotion and

disease prevention objectives of

‘‘Healthy People 2000,’’ a PHS-led

national activity to reduce morbidity

and mortality and improve the quality

of life. This announcement is related to

all of Healthy People 2000 priority

areas, except HIV Infection (an

announcement for HIV entitled, ‘‘Public

Health Conference Support Cooperative